news
Sterile compounded drug products voluntarily recalled
Compounded drug products are being voluntarily recalled due a lack of sterility assurance.
List view / Grid view
QA/QC
Filter the results
news
Pharmaceutical product development within the Fujifilm Group
Custom manufacturing of specialty chemicals and APIs.
news
MHRA announces recall of Zantac products made by GSK
The UK MHRA has issued an alert for the recall of unexpired Zantac products made by GSK due to the possible contamination of ranitidine in the medicines.
news
CQC registers UK clinic to prescribe medical cannabis
The CQC decision marks the first time the agency has accepted a clinic to prescribe patients with medical cannabis in the UK.
webinar
Ph. Eur. and USP changes – what every UV/Vis lab should know
4 October 2019 | By Mettler-Toledo GmbH
This webinar provides an overview of the important UV/Vis spectroscopy-relevant changes in both USP and Ph. Eur. taking a closer look at their impact and the solutions available to ensure compliance.
news
FDA recommends LC-HRMS to test for NDMA in ranitidine products
The FDA recommends drug manufacturers to use LC-HRMS to test for NDMA in ranitidine products, as high temperatures generate the impurity.
news
FDA and DEA send joint warning letters to illegal opioid sites
The FDA and DEA have, for the first time, sent joint warning letters to four networks which were illegally selling opioid products.
webinar
Limit ultrapure water system costs and downtime using Ozonia ozone technology
2 October 2019 | By SUEZ – Ozonia® Ozone Systems
The goal of this webinar is to familiarize companies with the applications and benefits of ozone technology in ultrapure water systems and Ozonia Membrel® electrolytic technology – SUEZ’s ozone product that produces ozone directly from water instead of gaseous air or oxygen.
news
Making Science Work at CPhI Worldwide 2019
CPhI Worldwide now comprises six individual pharma events and more than 20 dedicated zones.
product
On-demand webinar: Understanding and Applying USP 797
In an effort to prevent harm through contamination, the U.S. Pharmacopeial Convention has been working on a series of proposed changes to USP Chapter 797, Pharmaceutical Compounding– Sterile Preparations.
news
Survey finds shortages in all medicine categories in UK pharmacies
A survey of pharmacists has discovered that UK pharmacies experienced shortages across all 36 medicine categories in the last six months.
news
EMA releases guidance to companies on avoiding nitrosamines in drugs
The European Medicines Agency has issued advice to pharmaceutical companies on how to avoid the presence of nitrosamines in medicines.
article
How will technology aid an ageing world?
This article explores the potential of readily available technology to address current traceability challenges as well as more wide-ranging issues in the pharmaceutical industry.
news
Erenumab migraine drug fails to meet NICE recommendation standards
NICE has announced that it will not be recommending erenumab, an injectable migraine treatment, due to issues with cost and its long-term effectiveness.
news
Sandoz voluntarily recalls ranitidine over NDMA contamination concerns
The probable carcinogen N-nitrosodimethylamine was detected in Sandoz’s ranitidine capsules, prompting the voluntary move.